FDA Adverse Event Malfunction Summary report: N

ACTIVA

MDR report key: 2842535 · Received November 21, 2012

Report

Report Number
3007566237-2012-02809
Event Type
Malfunction
Date Received
November 21, 2012
Report Date
October 25, 2012
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ID: 748251, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2003, PRODUCT TYPE: EXTENSION; PRODUCT ID: 748251, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2002, PRODUCT TYPE: EXTENSION; PRODUCT ID: 7426, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2009, PRODUCT TYPE: IMPLANTABLE NEUROSTIMULATOR; PRODUCT ID: 3389-40, LOT#: J0228211V, IMPLANTED: (B)(6) 2003, PRODUCT TYPE: LEAD; PRODUCT ID: 3389-40, LOT#: J0228211V, IMPLANTED: (B)(6) 2002, PRODUCT TYPE: LEAD. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD BEEN FALLING. IT WAS ALSO REPORTED THAT THE IMPEDANCE ON CONTACT 2 OF THE RIGHT SIDE DEVICE WAS "APPROXIMATELY 16,000" OHMS. THE PATIENT WAS PROGRAMMED WITH THIS CONTACT, BUT HE WAS GETTING "GREAT BENEFIT". THE ABNORMAL IMPEDANCE WAS NOTICED THE DAY OF THE REPORT, BUT IT WAS POSSIBLE THAT THE IMPEDANCE PROBLEM PRE-DATED THAT SESSION. THE HEALTH CARE PROVIDER (HCP) WAS NOT "OVERLY CONCERNED" REGARDING THE HIGH IMPEDANCE BECAUSE THE PATIENT WAS GETTING "GOOD BENEFIT". IT WAS ALSO REPORTED THAT THE IMPEDANCE ON CONTACT 3 OF THE LEFT SIDE DEVICE WAS "AROUND 7500" OHMS, BUT THIS CONTACT WAS NOT USED IN PROGRAMMING SO THERE WAS NO CONCERN. ADDITIONAL INFORMATION RECEIVED ON (B)(4) 2012 REPORTED THAT THE PATIENT WAS DOING "WELL" AND THERE HAD BEEN NO FURTHER ISSUES. THE HCP HAD NO PLANS TO FOLLOW-UP WITH THE PATIENT AT THAT TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION 37602

Patients

Seq Age Sex Outcome Treatment
1